UNCY - Unicycive Therapeutics, Inc.
6.59
-0.240 -3.642%
Share volume: 692,030
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
-0.24
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-13-2024 | 05-14-2025 | 11-12-2025 | |
| Cash flow financing | 45.691 M | -811.000 K | -157.000 K | 2.546 M | 26.332 M | |
| Other financing cash flows | -496.000 K | 0.000 | 0.000 | -244.000 K | -815.000 K | |
| Cash flow | 39.229 M | -7.150 M | -9.433 M | -6.373 M | 20.368 M | |
| Net income | -20.963 M | 9.855 M | -4.096 M | 570.000 K | -6.011 M | |
| Depreciation | 9.000 K | 0.000 | 6.000 K | 8.000 K | 10.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.000 K | -20.000 K | -24.000 K | -16.000 K | -2.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.000 K | 20.000 K | 24.000 K | 16.000 K | 2.000 K | |
| Cash Change | 39.229 M | -7.150 M | -5.619 M | -6.373 M | 20.368 M |